Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“ Nadolol (1 μM), a β-adrenoceptor antagonist, decreased the incidence of ventricular fibrillation (30%) in a separate group of DMPX (10 μM) + ADO (10 μM) treated hearts (n = 6, P < .05 vs DMPX + ADO treated hearts).”